Sumary of Prevalence of transmitted resistance to common HIV drugs remains stable:
- July 20, 2021 2 min read Source/Disclosures Published by: Disclosures: McClung reports no relevant financial disclosures.
- Back to Healio The prevalence of transmitted resistance to common HIV drugs in the United States remained stable between 2014 and 2018, according to a study published recently in Clinical Infectious Diseases.
- This includes nucleotide sequence data from drug resistance testing,” R.
- The prevalence of transmitted resistance to coming HIV drugs has remained stable in the United States.
- Source: Shutterstock “These data provide valuable insight into population-level drug resistance patterns and can inform clinical guidelines for the management of HIV and PrEP,” McClung said.
- McClung explained that the study provided an updated look at transmitted drug resistance for non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors, and protease inhibitors.
- In a first, it also included the prevalence of transmitted resistance to integrase strand transfer inhibitors (INSTIs) from a large sample.
- “Standard genotypic drug resistance testing is recommended at entry into care for everyone with HIV in the U.S. to assist with selection of an initial ART regimen.